A
Dendreon Corp 3005 1st Avenue # 100 Category: Pharmaceutical Preparations |
Company representatives
Mark Frohlich, Chief Administrative Officer
Mitchell H Gold, President & Chief Executive Officer
Location Type
Headquarters
Revenue
$47,500,000 - $50,000,000
Employees
1,497
Years In Business
31
Stock symbol
DNDN
State of incorporation
Washington
SIC code
283401 (Drug-Manufacturers)
NAICS code
325412 (Pharmaceutical Preparation Manufacturing)
Rating
Browse U.S. states for Pharmaceutical Preparations
